Skip to main content
Caplight Logo









Angle Health

Angle Health

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://anglehealth.com

Last Round

Series C

Sep 18, 2026

Est. Valuation

$2.7B

Total Funding Raised

$396.15M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Angle Health operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series C round in September 2026.

Angle Health is a health insurance company that provides a full-stack, AI-enabled platform for employer-sponsored healthcare benefits.

Sector

Healthcare & Life Sciences

Verticals

InsurTech, Healthcare Analytics, Telemedicine

Business Model

B2B2C

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Angle Health Comparables

Compare Angle Health with similar companies based on industry and business-model similarity.

Angle Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sana Benefits
84%
Curative
83%
Pounce
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Angle Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CSep 18, 2026
Series BDec 3, 2025
Series AJan 25, 2023
SeedJul 21, 2020
AcceleratorMar 16, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Tylon W.

Co-Founder CEO

Founding Team

Rhett Thurman

Chief Financial Officer

Executive Team

For institutional investors. Book with your work email.

Angle Health Investors

Notable investors and investment history

Angle Health investors
InvestorRounds
Town Hall VenturesSeries C
Blumberg CapitalSeries C, Series B, Series A, Seed
SixThirty VenturesSeries B, Series A
Crew CapitalSeries A
Mighty CapitalSeries B, Series A
PruVen CapitalSeries C, Series B, Series A
Wing Venture CapitalSeries B, Series A
Book a demo to see all 17 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 18, 2026

    $200M round led by Vitruvian Partners

  • Jul 25, 2026

    Monthly visitors increased 137% MoM, reaching 32.1K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • partners_withOct 15, 2026

    Angle Health and Transcarent partner to give small and midsize employers' members access to coordinated MSK and surgical care, including orthopedic consultations, expert medical opinions, virtual physical therapy and surgical Centers of Excellence, beginning Jan 1st '27.

  • expands_offices_toSep 19, 2026

    Angle Health expands its presence from California, Texas, Florida, and Georgia to more than 25 states in 2024 and 2025, unlocking access for thousands of new small businesses.

  • has_valuationSep 18, 2026

    Angle Health reached a $2.7B valuation after raising a $200 million Series C alongside a $400 million tender offer.

  • receives_financingSep 18, 2026

    Angle Health announced a $200M Series C financing as part of a $600 million equity financing led by Vitruvian Partners, with participation from Town Hall Ventures, Blumberg Capital, Portage Ventures, PruVen Capital, and Y Combinator, expected to close later in September 2026 to continue expanding affordable healthcare access for small businesses.

  • receives_financingSep 18, 2026

    Angle Health receives $600M in equity financing, including a $200M Series C and a $400M tender offer led by Vitruvian Partners, on Oct 3rd '26.

Book a demo to see all news

For institutional investors. Book with your work email.

Angle Health Filings

Explore SEC and related filing metadata, where available.

Angle Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Angle Health's valuation, stock price, and market status.

Is Angle Health a public or private company?

Angle Health is a private company.

What is the current stock price of Angle Health?

Angle Health is a private company, so its shares have no public market price. Caplight tracks Angle Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Angle Health worth (valuation)?

Angle Health's valuation is estimated at $2.7B based on funding round data.

Can I buy Angle Health stock?

Angle Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Angle Health's last funding round?

Angle Health's most recent funding round was Series C on September 18, 2026.

Who are the main investors in Angle Health?

Key investors in Angle Health include Blumberg Capital, Y Combinator, Portage, Vitruvian Partners.

Will Angle Health IPO soon?

No public IPO plans have been announced for Angle Health.

How can I track Angle Health secondary market activity?

Caplight tracks bids, offers, and trades in Angle Health's shares on secondary markets.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range95
Year Founded2019
Last FundingSep 18, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?